• en
  • fr
Connect with Pendopharm on LinkedIn
Careers
Drug safety
Pendopharm
  • About Us
  • Prescription products
    • Gastroenterology
    • Orthopedics
    • Specialty medicine
  • Consumer products
    • Allergy
    • Cough, cold & sinus
    • Gastroenterology
    • Others
  • Partnerships
  • Newsroom
  • Contact Us
Connect with Pendopharm on LinkedIn
  • en
  • fr
Pendopharm
  • en
  • fr
Connect with Pendopharm on LinkedIn

GLATECT(TM) IS NOW COVERED BY THE PROVINCIAL DRUG PLAN IN BRITISH COLUMBIA FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS).

Newsroom

    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • December 13, 2018

    GLATECT(TM) IS NOW COVERED BY THE PROVINCIAL DRUG PLAN IN BRITISH COLUMBIA FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS).

    Read More
  • November 12, 2018

    PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award

    Read More
  • February 20, 2018

    Pendopharm a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals

    Read More
  • Prescription products
    • Gastroenterology
    • Orthopedics
    • Specialty medicine
  • Consumer products
    • Allergy
    • Cough, cold & sinus
    • Gastroenterology
    • Others
  • About Us
  • Partnerships
  • Newsroom
  • Contact Us
  • Disposing Unused/expired Medications
  • Terms and Conditions

Search by Product Name

Back to Top